 CAMBRIDGE, Mass., May 19, 2022 GLOBE NEWSWIRE -- Cullinan Oncology, Inc. Nasdaq: CGEM Cullinan a biopharmaceutical company focused on developing a diversified pipeline of targeted therapies for patients with cancer, today announced that its Chief Financial Officer, Jeff Trigilio, will present at the H.C. Wainwright Global Investment Conference, being held May 23-25 in Miami, FL and virtually. 